Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis
ACS Applied Materials & Interfaces · 20.05.2026 · 18 (19) · 27395-27411
DOI: 10.1021/acsami.6c06670 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 04.05.2026. Verfasst von Xiaoqiong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Regenerative Medicine and Multi-disciplinary Translational Research, Huazhong University of Science and Technology, Wuhan 430…. Hauptthemen laut MEDLINE: Meloxicam, Hydrogels, Tryptophan, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Major Scientific and Technological Innovation Projects of Hubei Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Regenerative Medicine and Multi-disciplinary Translational Research, Huazhong University of Science and Technology, Wuhan 430022, China.
- Hubei Provincial Engineering Research Center of Clinical Laboratory and Active Health Smart Equipment, Wuhan 430022, China.
- Hubei Clinical Research Center of Minimally Invasive Surgery, Wuhan 430022, China.
- Key Laboratory of Biological Targeted Therapy, Ministry of Education, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- The Department of Laboratory Medicine at Wuhan No. 4 Hospital, Wuhan 430033, China.
ORCID-Profile: Lin Wang, Zheng Wang
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Major Scientific and Technological Innovation Projects of Hubei Province
- Wuhan Natural Science Foundation Exploration Program
- Huazhong University of Science and Technology Interdisciplinary Research Support Program
- Major Scientific and Technological Innovation Projects of Wuhan
Zitieren
APA
Li, X., Xu, Y., Xu, L., Li, Q., Zhao, Y., Wei, C., Li, Y., Wang, L., & Wang, Z. (2026). Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis. ACS Applied Materials & Interfaces, 18(19), 27395-27411. https://doi.org/10.1021/acsami.6c06670
Vancouver
Li X, Xu Y, Xu L, Li Q, Zhao Y, Wei C, et al. Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis. ACS Applied Materials & Interfaces. 2026;18(19):27395-27411. doi:10.1021/acsami.6c06670
BibTeX
@article{Li2026,
author = {Li, Xiaoqiong and Xu, Yunruo and Xu, Luming and Li, Qilin and Zhao, Yiwei and Wei, Chunyu and Li, Yuyu and Wang, Lin and Wang, Zheng},
title = {Meloxicam-1- d -MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {19},
pages = {27395--27411},
doi = {10.1021/acsami.6c06670}
}
EUVIMED